0.8076
Io Biotech Inc stock is traded at $0.8076, with a volume of 333.84K.
It is down -5.00% in the last 24 hours and down -1.79% over the past month.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
See More
Previous Close:
$0.8501
Open:
$0.86
24h Volume:
333.84K
Relative Volume:
0.09
Market Cap:
$58.11M
Revenue:
-
Net Income/Loss:
$-86.08M
P/E Ratio:
-0.3743
EPS:
-2.1574
Net Cash Flow:
$-72.06M
1W Performance:
+15.92%
1M Performance:
-1.79%
6M Performance:
-46.16%
1Y Performance:
+2.00%
Io Biotech Inc Stock (IOBT) Company Profile
Name
Io Biotech Inc
Sector
Industry
Phone
(457) 070-2980
Address
OLE MAALOES VEH 3, COPENHAGEN
Compare IOBT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
IOBT
Io Biotech Inc
|
0.8076 | 61.16M | 0 | -86.08M | -72.06M | -2.1574 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Io Biotech Inc Stock (IOBT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-30-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Sep-30-25 | Downgrade | TD Cowen | Buy → Hold |
Io Biotech Inc Stock (IOBT) Latest News
IO Biotech, Inc. (NASDAQ:IOBT) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
IO Biotech (NASDAQ:IOBT) Stock Rating Lowered by Wall Street Zen - MarketBeat
Nothing is Better Than IO Biotech Inc (IOBT) stock at the moment - Setenews
What margin trends mean for IO Biotech Inc stock2025 Winners & Losers & AI Powered Trade Plan Recommendations - BỘ NỘI VỤ
IO Biotech (IOBT) Stock Analysis Report | Financials & Insights - Benzinga
How does IO Biotech Inc (IOBT) change from a tortoise to a hare? - Setenews
Will IO Biotech Inc. stock reach all time highs in 2025July 2025 Levels & Growth Focused Stock Reports - moha.gov.vn
Research Recommendations For IO Biotech Inc (IOBT): Here is What You Should Know - fostersleader.com
Analyst Downgrade: How IO Biotech Inc. stock benefits from strong dollarJuly 2025 Movers & Free Growth Oriented Trading Recommendations - moha.gov.vn
How strong is IO Biotech Inc. stock balance sheetMarket Performance Recap & Long-Term Safe Investment Plans - BỘ NỘI VỤ
Aug Wrap: What margin trends mean for IO Biotech Inc. stockJuly 2025 Decliners & Real-Time Volume Analysis Alerts - moha.gov.vn
IO Biotech Announces Participation in Upcoming December Investor Conferences - The Manila Times
IO Biotech (Nasdaq: IOBT) to Join Evercore, Piper Sandler December Investor Events - Stock Titan
IOBTRemeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For - mx.advfn.com
It makes sense and dollars to buy IO Biotech Inc (IOBT) stock - Setenews
Ligand Pharmaceuticals (NASDAQ:LGND) and IO Biotech (NASDAQ:IOBT) Financial Review - Defense World
IO Biotech (NASDAQ:IOBT) Stock Rating Upgraded by Wall Street Zen - Defense World
IO Biotech announces resignation of chief accounting officer and new appointment - Investing.com Australia
IO Biotech Announces Resignation of Chief Accounting Officer - MSN
IO Biotech announces resignation of chief accounting officer and new appointment By Investing.com - Investing.com South Africa
IO Biotech Announces Management Changes - TradingView
[8-K] IO Biotech, Inc. Reports Material Event | IOBT SEC FilingForm 8-K - Stock Titan
IO Biotech, Inc. Announces Executive Changes - MarketScreener
Can IO Biotech Inc. stock withstand economic slowdown2025 Retail Activity & Risk Controlled Daily Trade Plans - newser.com
IO Biotech’s Q3 2025: Progress in Cancer Vaccine Trials - MSN
Remeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For - The Spec
Piper Sandler reiterates Overweight rating on IO Biotech stock By Investing.com - Investing.com South Africa
Is IO Biotech Inc. stock entering bullish territoryJuly 2025 Review & Fast Gaining Stock Reports - newser.com
Is IO Biotech Inc. stock a top momentum playWeekly Stock Analysis & Daily Price Action Insights - newser.com
IO Biotech, Inc. (IOBT) Upgraded to Buy: Here's Why - Yahoo Finance
Will IO Biotech Inc. stock deliver long term returns2025 Support & Resistance & High Conviction Buy Zone Picks - newser.com
Piper Sandler reiterates Overweight rating on IO Biotech stock - Investing.com India
IO Biotech Inc. (IOBT) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is IO Biotech Inc. stock safe for conservative investorsPortfolio Return Summary & Reliable Volume Spike Alerts - newser.com
IO Biotech Presents at Jefferies Global Healthcare Conference - MSN
IO Biotech Inc (IOBT) is looking forward to a strong quarter - Setenews
IO Biotech, Inc. Updates on Cylembio Phase 3 Trial Results - TradingView
Will IO Biotech Inc. see short term momentum2025 Top Gainers & Technical Confirmation Trade Alerts - newser.com
Sector ETF performance correlation with IO Biotech Inc.Market Trend Review & Smart Allocation Stock Reports - newser.com
Is IO Biotech Inc. meeting your algorithmic filter criteriaEarnings Miss & High Conviction Investment Ideas - newser.com
What moving averages say about IO Biotech Inc.Stock Surge & Low Risk High Reward Trade Ideas - newser.com
IO Biotech’s Hold Rating Amid Financial and Regulatory Uncertainty - TipRanks
Will IO Biotech Inc. stock outperform tech sector in 2025Bull Run & Weekly High Momentum Picks - newser.com
IO Biotech, Inc.Common Stock (Nasdaq:IOBT) Detailed Stock Data | PRN_FinancialWrapper | PR Newswire - Markets Financial Content
Io Biotech Inc Stock (IOBT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):